Biotoxtech Co., Ltd.

KOSDAQ:A086040 株式レポート

時価総額：₩81.2b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Biotoxtech マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Jong-Koo Kang

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権14.4%
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Is Biotoxtech (KOSDAQ:086040) A Risky Investment?

May 06
Is Biotoxtech (KOSDAQ:086040) A Risky Investment?

Estimating The Fair Value Of Biotoxtech Co., Ltd. (KOSDAQ:086040)

Mar 28
Estimating The Fair Value Of Biotoxtech Co., Ltd. (KOSDAQ:086040)

Did Biotoxtech's (KOSDAQ:086040) Share Price Deserve to Gain 91%?

Feb 20
Did Biotoxtech's (KOSDAQ:086040) Share Price Deserve to Gain 91%?

Are Robust Financials Driving The Recent Rally In Biotoxtech Co., Ltd.'s (KOSDAQ:086040) Stock?

Jan 24
Are Robust Financials Driving The Recent Rally In Biotoxtech Co., Ltd.'s (KOSDAQ:086040) Stock?

We're Not So Sure You Should Rely on Biotoxtech's (KOSDAQ:086040) Statutory Earnings

Dec 27
We're Not So Sure You Should Rely on Biotoxtech's (KOSDAQ:086040) Statutory Earnings

Is Biotoxtech (KOSDAQ:086040) Using Too Much Debt?

Nov 30
Is Biotoxtech (KOSDAQ:086040) Using Too Much Debt?

CEO（最高経営責任者

Jong-Koo Kang (69 yo)

no data

在職期間

Mr. Jong-Koo Kang, Ph.D. has been the Chief Executive Officer of Biotoxtech Co., Ltd since 2000. Mr. Kang served as the President of Korean Association for Laboratory Animal Science. He was Director-in-Chi...